
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES138
One RCT250 found significantly lower HbA1c levels in doxazosin-treated patients as compared to patients receiving irbesartan after 12 months of follow-up. Level 1+

[@Whelton_2005]

